Pennant Group [PNTG] vs Astrana Health [ASTH] Detailed Stock Comparison

Pennant Group, Inc.

NASDAQ
Loading...

Astrana Health Inc.

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Pennant Group, Inc. wins in 11 metrics, Astrana Health Inc. wins in 9 metrics, with 0 ties. Pennant Group, Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Pennant Group, Inc. Astrana Health Inc. Better
P/E Ratio (TTM) 34.94 73.30 Pennant Group, Inc.
Price-to-Book Ratio 3.08 2.12 Astrana Health Inc.
Debt-to-Equity Ratio 122.87 193.10 Pennant Group, Inc.
PEG Ratio 0.74 -0.41 Pennant Group, Inc.
EV/EBITDA 24.80 14.57 Astrana Health Inc.
Profit Margin (TTM) 3.12% 0.71% Pennant Group, Inc.
Operating Margin (TTM) 6.25% 1.85% Pennant Group, Inc.
EBITDA Margin (TTM) 6.25% 1.85% Pennant Group, Inc.
Return on Equity 9.84% 4.49% Pennant Group, Inc.
Return on Assets (TTM) 3.90% 3.43% Pennant Group, Inc.
Free Cash Flow (TTM) $36.26M $104.49M Astrana Health Inc.
1-Year Return 19.30% 51.75% Astrana Health Inc.
Price-to-Sales Ratio (TTM) 1.07 0.59 Astrana Health Inc.
Enterprise Value $1.49B $2.10B Astrana Health Inc.
EV/Revenue Ratio 1.57 0.66 Astrana Health Inc.
Gross Profit Margin (TTM) 13.57% 10.00% Pennant Group, Inc.
Revenue per Share (TTM) $27 $65 Astrana Health Inc.
Earnings per Share (Diluted) $0.84 $0.46 Pennant Group, Inc.
Beta (Stock Volatility) 1.30 0.77 Astrana Health Inc.
Short % of Float 2.42% 8.35% Pennant Group, Inc.

Pennant Group, Inc. vs Astrana Health Inc. Stock Performance Analysis

Loading Price Chart...

PNTG
ASTH

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Pennant Group, Inc.-1.65%-10.74%-2.41%-8.09%4.37%9.05%
Astrana Health Inc.3.13%-4.80%4.83%49.61%59.30%45.40%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Pennant Group, Inc.19.30%176.21%1.75%114.06%114.06%114.06%
Astrana Health Inc.51.75%11.50%1.87%585.25%637.65%637.65%

Performance & Financial Health Analysis: Pennant Group, Inc. vs Astrana Health Inc.

MetricPNTGASTH
Market Information
Market Cap i$1.05B$1.88B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i152,152497,178
90 Day Avg. Volume i226,704435,283
Last Close$30.35$37.85
52 Week Range$21.73 - $37.54$18.08 - $39.93
% from 52W High-19.15%-5.21%
All-Time High$69.56 (Jan 04, 2021)$133.23 (Nov 15, 2021)
% from All-Time High-56.37%-71.59%
Growth Metrics
Quarterly Revenue Growth0.53%0.43%
Quarterly Earnings Growth0.50%0.43%
Financial Health
Profit Margin (TTM) i0.03%0.01%
Operating Margin (TTM) i0.06%0.02%
Return on Equity (TTM) i0.10%0.04%
Debt to Equity (MRQ) i122.87193.10
Cash & Liquidity
Book Value per Share (MRQ)$9.54$15.94
Cash per Share (MRQ)$0.49$8.68
Operating Cash Flow (TTM) i$48.29M$114.60M
Levered Free Cash Flow (TTM) i$7.21M$227.95M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Pennant Group, Inc. vs Astrana Health Inc.

MetricPNTG (Apr 24, 2026)ASTH (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i34.9473.30
Forward P/E i18.7110.50
PEG Ratio i0.74-0.41
Price to Sales (TTM) i1.070.59
Price to Book (MRQ) i3.082.12
Market Capitalization
Market Capitalization i$1.05B$1.88B
Enterprise Value i$1.49B$2.10B
Enterprise Value Metrics
Enterprise to Revenue i1.570.66
Enterprise to EBITDA i24.8014.57
Risk & Other Metrics
Beta i1.300.77
Book Value per Share (MRQ) i$9.54$15.94

Financial Statements Comparison: Pennant Group, Inc. vs Astrana Health Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricPNTG (2025)ASTH (2025)
Revenue/Sales i947.71M3.18B
Cost of Goods Sold i817.20M2.84B
COGS % of Revenue i86.2%89.3%
Gross Profit i130.50M341.53M
Gross Margin i13.8%10.7%
Research & Development iN/AN/A
Operating Income (EBIT) i50.89M78.53M
Operating Margin i5.4%2.5%
EBITDA i59.85M135.35M
EBITDA Margin i6.3%4.3%
Pre-Tax Income i45.63M39.61M
Pre-Tax Income % of Revenue i4.8%1.2%
Income Tax i11.87M15.53M
Income Tax % of Revenue i1.3%0.5%
Net Income (Profit) i33.76M24.08M
Profit Margin i3.6%0.8%

Balance Sheet & Liquidity Metrics

MetricPNTG (2025)ASTH (2025)
Cash & Equivalents i17.02M429.47M
Total Current Assets i167.41M863.31M
Total Current Assets % of Revenue i17.7%27.1%
Total Current Liabilities i147.26M615.27M
Total Current Liabilities % of Revenue i15.5%19.3%
Long-Term Debt i423.15M1.02B
Long-Term Debt % of Revenue i44.6%32.1%
Total Shareholders Equity i374.25M558.33M
Retained Earnings i86.80M308.38M
Retained Earnings % of Revenue i9.2%9.7%
Property, Plant & Equipment i313.64M35.74M

Cash Flow Statement Comparison

MetricPNTG (2025)ASTH (2025)
Operating Cash Flow i33.89M109.88M
Operating Cash Flow % of Revenue i3.6%3.5%
Capital Expenditures i-12.04M-10.11M
Free Cash Flow i36.26M104.49M
FCF Margin i3.8%3.3%
Debt Repayment i-298.00M-495.29M
Common Stock Repurchase iN/A-15.43M

Short Interest & Institutional Ownership Analysis

MetricPNTGASTH
Shares Short i797,4562.68M
Short Ratio i3.006.86
Short % of Float i2.42%8.35%
Shares Outstanding i34.63M48.89M
Float Shares i33.00M44.36M
% Held by Insiders i5.00%20.32%
% Held by Institutions i97.01%52.52%
% Held by Public i-2.01%27.16%

Dividend Analysis & Yield Comparison: Pennant Group, Inc. vs Astrana Health Inc.

MetricPNTGASTH
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A